Stock Report

Download full stock data and analysis for free Last Updated: 07-May-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Eyenovia Inc. (EYEN)

Stock Card factsheet share-fund-plan-icon

$7.08

up-down-arrow $-8.74 (-55.25%)

As on 01-Aug-2025 09:30EDT

Market cap

info icon

$81 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

36.2

Div. Yield

info icon

0 %

Eyenovia (EYEN) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Price P/E Ratio P/B Ratio
NASDAQ
NASDAQ

Stock Range

Today’s Range

Low: 6.61 High: 7.75

52 Week Range

Low: 0.85 High: 104.00

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -3.9 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    26.19

  • EV/EBITDAEV/EBITDA information

    -5.4

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $--

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    5,104,360

9 Years Aggregate

CFO

$-120.00 Mln

EBITDA

$-135.28 Mln

Net Profit

$-138.85 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Eyenovia (EYEN)
-39.4 -31.8 532.1 -92.9 -62.7 -52.1 --
BSE Sensex*
-8.1 5.0 -6.9 -3.5 8.4 9.7 11.9
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 01-Aug-2025  |  *As on 07-May-2026  |  #As on 26-Oct-2023
Company
2024
2023
2022
2021
2020
2019
Eyenovia (EYEN)
-92.8 27.6 -59.3 -34.0 35.3 57.2
S&P Small-Cap 600
7.0 13.9 -17.4 25.3 9.6 20.9
BSE Sensex
8.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
Quarterly Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Eyenovia (EYEN)

Eyenovia, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license...  agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi; and agreement with Formosa Pharmaceuticals. Inc. for Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was founded in 2014 and is based in New York, New York.  Read more

  • Co-Founder & Executive Chairman

    Dr. Tsontcho Ianchulev M.D., M.P.H., MPH

  • Co-Founder & Executive Chairman

    Dr. Tsontcho Ianchulev M.D., M.P.H., MPH

  • Headquarters

    New York, NY

  • Website

    https://www.eyenovia.com

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

FAQs for Eyenovia (EYEN)

The share price of Eyenovia Inc (EYEN) is $7.08 (NASDAQ) as of 01-Aug-2025 09:30 EDT. Eyenovia Inc (EYEN) has given a return of -62.66% in the last 3 years.

Since, TTM earnings of Eyenovia Inc (EYEN) is negative, P/E ratio is not available.
The P/B ratio of Eyenovia Inc (EYEN) is 36.17 times as on 01-Aug-2025, a 468 premium to its peers’ median range of 6.37 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2024
--
--
2023
--
--
2022
--
--
2021
--
--
2020
--
--

The 52-week high and low of Eyenovia Inc (EYEN) are Rs 104.00 and Rs 0.85 as of 07-May-2026.

Eyenovia Inc (EYEN) has a market capitalisation of $ 81 Mln as on 01-Aug-2025. As per SEBI classification, it is a Small Cap company.

Before investing in Eyenovia Inc (EYEN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.